- This event has passed.
Symposium The Burden of Antimicrobial resistance in the Netherlands: Utrecht, the Netherlands
Antibiotic resistance has become a global health problem. Over the past few years, several attempts have been made to quantify the burden of disease caused by antibiotic resistance, with some predicting that by 2050 10 million people will die because of antibiotic resistance, per year! This so-called attributable mortality – the fraction of mortality in infections that can be attributed to antibiotic resistance – has now also been estimated for major antibiotic-resistant pathogens in the Netherlands. In this symposium, preceding the PhD defense ceremony of Wouter Rottier, these findings will be contrasted to international findings.
The quantified burden of antibiotic-resistant pathogens, or the perceived burden, underlies decision making for infection control measures to limit spread of such bacteria in healthcare settings. In light of the new findings on the burden of antibiotic-resistant bacteria in the Netherlands, the justification for the ‘highly resistant micro-organisms’ (BRMO) status will be debated. Regardless of the outcome of the debates, they will provide food for thought!
9.00-9.30 The burden of antibiotic resistance in Europe
Melanie Colomb-Cotinat (Unité Résistance aux Antibiotiques et Infections associées aux soins) and ECDC
9.30-10.15 The burden of antibiotic resistance in the Netherlands
Wouter Rottier, UMCU/UMCG
10.15-10.45 Pro-Con: VRE should no longer be on the list of BRMO
Marc Bonten (UMCU) vs Andreas Voss (UMCRadboud)
10.45-11.15 Coffee break
11.15-11.45 Pro-Con: LA-MRSA should no longer be on the list of BRMO
Martin Bootsma (UMCU) vs TBD
11.45-12.15 Pro-Con: E. coli ESBL should no longer be on the list of BRMO
Andreas Widmer (Basel) vs Marjolein Kluytmans-van den Bergh (Amphia ziekenhuis/UMCU)
12.15-12.45 What are the external risks for the current situation on antibiotic resistance in the Netherlands
Alexander Friedrich (UMCG)
12.45-13.15 The international response to fight against antibiotic resistance
Seamus O’Brien (scientific director GARDP)
13.15-14.00 Lunch and departure